Work

OA09 Preliminary Clinical Activity of Repotrectinib (TPX-0005) in Advanced ROS1 Fusion-Positive Non-Small Cell Lung Cancer

Year: 2018

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2018.10.019

Authors: S. Ou, B.C. Cho, D. Kim, A. Drilon, J. Lee, J. Lin, V. Zhu, M. Ahn, D.R. Camidge, S. Shanna Stopatschinskaja, J. Liu, J. Cui, D. Hyman, R. Doebele, A. Shaw

Institutions: University of California, Irvine, Yonsei University, Yonsei Cancer Hospital, Seoul National University Hospital, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Samsung Medical Center, Sungkyunkwan University, Harvard University, Massachusetts General Hospital, University of Colorado Anschutz, University of Colorado Denver

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2903610182

Cites:

Cited by: 5

Related to: 10